# The Leadless AV Versus DDD Pacing Study

Study · id `cardio:ct-nct05498376` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05498376](<https://clinicaltrials.gov/study/NCT05498376>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05498376

Browse, organ or system: Heart  
Browse, condition area: Heart rhythm problems  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 100 participants.

## Technical summary

Registry record NCT05498376. Randomized; no masking; primary purpose treatment. Start 2022-08-23 (actual); primary completion 2026-12-31 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 100 participants (planned count; ClinicalTrials.gov record NCT05498376, source copy `cardio:ctgov-nct05498376-2026-04-29`, retrieved 2026-10-26)
- Started: 2022-08-23 (actual) (ClinicalTrials.gov record NCT05498376, source copy `cardio:ctgov-nct05498376-2026-04-29`, retrieved 2026-10-26)
- Primary completion: 2026-12-31 (anticipated) (ClinicalTrials.gov record NCT05498376, source copy `cardio:ctgov-nct05498376-2026-04-29`, retrieved 2026-10-26)
- Completion: 2027-12-31 (anticipated) (ClinicalTrials.gov record NCT05498376, source copy `cardio:ctgov-nct05498376-2026-04-29`, retrieved 2026-10-26)
- Countries: Switzerland (ClinicalTrials.gov record NCT05498376, source copy `cardio:ctgov-nct05498376-2026-04-29`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "ACTIVE\_NOT\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05498376-2026-04-29`, retrieved 2026-10-26)

## The registry's words

- Brief title: The Leadless AV Versus DDD Pacing Study
- Acronym: LEAVE DDD
- Condition: Cardiac Pacemaker
- Condition: Arrhythmias, Cardiac
- Condition: Heart Diseases
- Condition: Cardiovascular Diseases
- Intervention (Device): Conventional pacemaker DDD
- Intervention (Device): Leadless pacemaker Micra AV
- Lead sponsor: Insel Gruppe AG, University Hospital Bern
- Lead sponsor class: OTHER
- Collaborator: University of Bern
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry lists this organization as the lead sponsor: Insel Gruppe AG, University Hospital Bern (`cardio:org-insel-gruppe-ag-university-hospital-bern`)
- Registry lists this organization as a collaborator: University of Bern (`cardio:org-university-of-bern`)

## Provenance

Content hash: a514a2261528942bf81c1cf5ab613ba213af721b69cffeb1cf1df80b3a657f34
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
